این سایت در حال حاضر پشتیبانی نمی شود و امکان دارد داده های نشریات بروز نباشند
International Journal of Hematology-Oncology and Stem Cell Research، جلد ۱۳، شماره ۴، صفحات ۲۰۱-۲۰۷
عنوان فارسی
چکیده فارسی مقاله
کلیدواژه‌های فارسی مقاله
عنوان انگلیسی Outcome of Acute Deep Venous Thrombosis Using Standard Treatment versus Thrombolytics: A Literature Review
چکیده انگلیسی مقاله Deep vein thrombosis (DVT) is a major health problem affecting a significant portion of population. Primary complications are Pulmonary Embolism (PE) in the short term and Post-Thrombotic Syndrome (PTS) in the long term. Thrombolytic drugs act by activating plasminogen which in turn forms the enzyme plasmin. Plasmin consequently degrades blood clots by breaking down the fibrin molecules which make up the clots help to degrade the already formed clot. They can be used using different route of administration, doses and durations. The purpose of this systematic review was to assess the outcome of thrombolytic therapy in terms of the efficacy, safety and effectiveness of the medicines. Electronic searches of databases (MEDLINE and Google Scholar) were queried for articles written in English since 2000 GC. A total of 760 results were obtained using the search keys, and after excluding duplicates, 275 articles were selected. Finally, 9 randomized controlled trials (RCTs) which met the language of publication, study design and exclusion criteria were included in this systematic review. The data were obtained from nine trials (6 countries), providing a study-level data of 1309 participants. Almost all studies revealed that thrombolytic treatment was effective in the management of acute DVT. In most of the studies, the rate of rethrombosis was lower in case of thrombolytic than standard management. Hence, addition of thrombolytic results in persistence and increases the clinical benefits. Thrombolytic therapy was very effective in reversing closed veins, in boosting the patency rate, while reflux was higher in patients treated with anticoagulants. Thrombolytic offers potential advantages over the standard treatment of DVT by reducing the proportion of patients with chronic disabling leg symptoms (such as PTS) by triple in the longer term. However, the incident of major bleeding was higher in patients receiving thrombolytics
کلیدواژه‌های انگلیسی مقاله
نویسندگان مقاله | Abdella Birhan
Department of Pharmacology and Clinical Pharmacy, School of Pharmacy, Addis Ababa University (AAU), Addis Ababa, Ethiopia


| Tamrat Assefa
Department of Pharmacology and Clinical Pharmacy, School of Pharmacy, Addis Ababa University (AAU), Addis Ababa, Ethiopia


| Alemseged Beyene
Department of Pharmacology and Clinical Pharmacy, School of Pharmacy, Addis Ababa University (AAU), Addis Ababa, Ethiopia


| Pacifique Ndayishimiye
Department of Clinical Pharmacy and Pharmacology, School of Pharmacy, Muhimbili Health and Allied Sciences (MUHAS), Dar Es Salaam, Tanzania


| Minyahil Woldu
Department of Pharmacology and 1) Clinical Pharmacy, School of Pharmacy, Addis Ababa University (AAU), Addis Ababa, Ethiopia 2)2Department of Clinical Pharmacy and Pharmacology, School of Pharmacy, Muhimbili Health and Allied Sciences (MUHAS), Dar Es Salaam, Tanzania
نشانی اینترنتی http://ijhoscr.tums.ac.ir/index.php/ijhoscr/article/view/1061
فایل مقاله اشکال در دسترسی به فایل - ./files/site1/rds_journals/78/article-78-1970066.pdf
کد مقاله (doi)
زبان مقاله منتشر شده
موضوعات مقاله منتشر شده
نوع مقاله منتشر شده
برگشت به: صفحه اول پایگاه   |   نسخه مرتبط   |   نشریه مرتبط   |   فهرست نشریات